American Century Companies Inc. Purchases 30,764 Shares of Haleon PLC Sponsored ADR $HLN

Key Points

• American Century Companies Inc. increased its holdings in Haleon PLC by purchasing an additional 30,764 shares, bringing its total to 750,654 shares valued at approximately $7.72 million.
• Major institutional investors have also boosted their positions in Haleon, with Deutsche Bank AG increasing its stake by 267.8% during the first quarter.
• Haleon recently announced a new semi-annual dividend of $0.0555 per share, up from the previous $0.05, reflecting a dividend yield of 190%.

American Century Companies Inc. increased its position in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 4.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 750,654 shares of the company's stock after buying an additional 30,764 shares during the quarter. American Century Companies Inc.'s holdings in Haleon were worth $7,724,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Nuveen LLC purchased a new stake in shares of Haleon in the first quarter worth approximately $58,870,000. Point72 Asset Management L.P. purchased a new stake in shares of Haleon in the fourth quarter worth approximately $45,110,000. Northern Trust Corp raised its stake in shares of Haleon by 27.7% in the fourth quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock worth $51,636,000 after purchasing an additional 1,172,931 shares during the last quarter. Royal Bank of Canada raised its stake in shares of Haleon by 62.6% in the fourth quarter. Royal Bank of Canada now owns 2,733,615 shares of the company's stock worth $26,078,000 after purchasing an additional 1,052,462 shares during the last quarter. Finally, Voloridge Investment Management LLC purchased a new stake in shares of Haleon in the fourth quarter worth approximately $5,499,000. 6.67% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective for the company in a research note on Tuesday, May 27th. Wall Street Zen downgraded Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. BNP Paribas raised Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Barclays reaffirmed an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Finally, Morgan Stanley raised Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target for the company in a research report on Friday, May 9th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Haleon has a consensus rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Stock Performance

NYSE HLN traded up $0.12 on Monday, hitting $9.81. 8,278,049 shares of the stock traded hands, compared to its average volume of 8,264,119. The business's fifty day moving average is $9.85 and its two-hundred day moving average is $10.21. Haleon PLC Sponsored ADR has a 12 month low of $8.86 and a 12 month high of $11.42. The firm has a market capitalization of $43.96 billion, a price-to-earnings ratio of 25.14, a PEG ratio of 2.89 and a beta of 0.23. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87.

Haleon Increases Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 18th. Shareholders of record on Friday, August 15th will be issued a dividend of $0.0555 per share. This represents a yield of 190.0%. This is a positive change from Haleon's previous semi-annual dividend of $0.05. The ex-dividend date of this dividend is Friday, August 15th. Haleon's dividend payout ratio is currently 28.21%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.